These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6216082)

  • 1. The effect of some beta-lactam antibiotics on Escherichia coli studied by flow cytometry.
    Martinez OV; Gratzner HG; Malinin TI; Ingram M
    Cytometry; 1982 Sep; 3(2):129-33. PubMed ID: 6216082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cefazolin and moxalactam on serum chemistry values determined by autoanalyzer.
    Polk RE; Stephens GH
    Am J Hosp Pharm; 1981 Jun; 38(6):866-8. PubMed ID: 6454343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
    Baumgärtner M; Dickgiesser N; Müller S; Wundt W
    Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of beta-lactamase stability, penetration, and target affinity on the activity of cefazolin, cefamandole, cefoxitin, and cefuroxime.
    Harper PB
    Clin Ther; 1984; 6(3):310-24. PubMed ID: 6609771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Escherichia coli susceptibility to cephalothin, cefazolin, ceforanide, and cefamandole.
    Greenberg RN; Bollinger M
    Clin Ther; 1985; 7(2):151-3. PubMed ID: 3886140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
    Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Moxalactam: preclinical evaluation].
    Chabbert YA
    Sem Hop; 1983 Jun; 59(26):1943-6. PubMed ID: 6310782
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of intradiscal antibiotics for discography: an in vitro study of gentamicin, cefazolin, and clindamycin.
    Klessig HT; Showsh SA; Sekorski A
    Spine (Phila Pa 1976); 2003 Aug; 28(15):1735-8. PubMed ID: 12897501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial defence against antibiotics.
    Normark S; Bergström S; Edlund T; Grundström T; Jaurin B
    Scand J Infect Dis Suppl; 1980; Suppl 24():188-94. PubMed ID: 7010556
    [No Abstract]   [Full Text] [Related]  

  • 10. Atomic force microscopy study of different effects of natural and semisynthetic beta-lactam on the cell envelope of Escherichia coli.
    Yang L; Wang K; Tan W; He X; Jin R; Li J; Li H
    Anal Chem; 2006 Oct; 78(20):7341-5. PubMed ID: 17037942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters.
    Verbist L
    Arzneimittelforschung; 1981; 31(6):982-6. PubMed ID: 6266430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in ultrastructure of Escherichia coli under the effect of certain antibiotics].
    Zhukov VG; Navashin SM; Berezina EK
    Antibiotiki; 1976 May; 21(5):429-34. PubMed ID: 799488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases.
    Sougakoff W; Jarlier V
    J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():9-14; discussion 63-5. PubMed ID: 11051618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of beta-lactam and non-beta-lactam antibiotics in extended-spectrum beta-lactamase-producing clinical isolates of Escherichia coli.
    Puerto AS; Fernández JG; del Castillo Jde D; Pino MJ; Angulo GP
    Diagn Microbiol Infect Dis; 2006 Feb; 54(2):135-9. PubMed ID: 16406187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of subinhibiting concentrations of fosfomycin on the ultrastructure of E. coli K 126].
    Carlone NA; Cattaneo O; Cuffini AM; Ferrero M
    G Batteriol Virol Immunol; 1980; 73(7-12):260-71. PubMed ID: 7030849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of anti-microbial resistance of Escherichia coli that caused infection in urogenital system].
    Cui WL; Xu DX; Li WL; Wang LX
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug; 24(8):940-2, 945. PubMed ID: 15321769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid assessment of ceftazidime, ciprofloxacin, and gentamicin susceptibility in exponentially-growing E. coli cells by means of flow cytometry.
    Walberg M; Gaustad P; Steen HB
    Cytometry; 1997 Feb; 27(2):169-78. PubMed ID: 9012384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of flow cytometry to the study of bacterial responses to antibiotics.
    Gant VA; Warnes G; Phillips I; Savidge GF
    J Med Microbiol; 1993 Aug; 39(2):147-54. PubMed ID: 8345510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sensitivity of nanoparticlized cefazolin sodium to the bacteria in vitro].
    Zou L; Fan XG; Gui H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):318-20. PubMed ID: 16045023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.